Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 138 of 151

  1. Vitamin D3

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 2 other completed

    1 trial

  2. Vitamin E

    NORTHWEST BIOTHERAPEUTICS INC

    Nonalcoholic Fatty Liver Disease

    phase 2 small molecule completed

    1 trial

  3. Vixarelimab

    Kiniksa Pharmaceuticals International, plc

    Prurigo Nodularis

    phase 2 small molecule completed

    1 trial

  4. Vociprotafib

    Revolution Medicines

    Metastatic Neoplasm

    phase 2 small molecule terminated

    1 trial

  5. Voclosporin

    Aurinia Pharmaceuticals

    Covid19

    phase 2 small molecule completed

    1 trial

  6. Voclosporin

    Aurinia Pharmaceuticals

    Focal Segmental Glomerulosclerosis

    phase 2 small molecule terminated

    1 trial

  7. Voclosporin

    Aurinia Pharmaceuticals

    Kidney Diseases

    phase 2 small molecule completed

    1 trial

  8. Voclosporin High Dose

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 2 small molecule completed

    1 trial

  9. Voclosporin Ophthalmic Solution

    Aurinia Pharmaceuticals

    Dry Eye

    phase 2 small molecule completed

    1 trial

  10. Vodobatinib (K0706) capsules

    Advanced Accelerator Applications

    Healthy (For Part A)

    phase 2 small molecule terminated

    1 trial

  11. Volixibat

    Mirum Pharmaceuticals International B.V.

    Intrahepatic Cholestasis of Pregnancy

    phase 2 small molecule terminated

    1 trial

  12. Volixibat

    Mirum Pharmaceuticals International B.V.

    Primary Sclerosing Cholangitis

    phase 2 small molecule active

    1 trial

  13. Volixibat

    Mirum Pharmaceuticals International B.V.

    Primary Biliary Cholangitis

    phase 2 small molecule active

    1 trial

  14. Volrustomig

    AstraZeneca

    Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)

    phase 2 mab active

    1 trial

  15. Vonafexor

    Lacuna Pharma Pty Ltd

    Alport Syndrome

    phase 2 small molecule active

    1 trial

  16. Vonoprazan

    Takeda

    Gastroesophageal Reflux

    phase 2 small molecule completed

    1 trial

  17. Vonoprazan

    Phathom Pharmaceuticals

    Eosinophilic Esophagitis

    phase 2 small molecule active

    1 trial

  18. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

  19. Vortioxetine

    Takeda

    Binge Eating Disorder

    phase 2 small molecule completed

    1 trial

  20. Vortioxetine

    COGNITION THERAPEUTICS INC

    Post-COVID-19 Condition

    phase 2 small molecule completed

    1 trial

  21. Vortioxetine (IV)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  22. Vosoritide Injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Idiopathic Short Stature

    phase 2 small molecule active

    1 trial

  23. Vosoritide Injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Noonan Syndrome

    phase 2 small molecule active

    1 trial

  24. WA39085

    Hoffmann-La Roche

    Relapsing-Remitting Multiple Sclerosis (RRMS)

    phase 2 small molecule active

    1 trial

  25. WA42985

    Hoffmann-La Roche

    Lupus Nephritis (LN)

    phase 2 small molecule active

    1 trial

  26. WBRT

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 other active

    1 trial

  27. WJMSCs Vs. placebo

    The First People's Hospital of Lianyungang

    Ischemic Cardiomyopathy

    phase 2 mab active

    1 trial

  28. WO39608

    Hoffmann-La Roche

    Pancreatic ductal adenocarcinoma (PDAC)

    phase 2 small molecule active

    1 trial

  29. WO42178

    Hoffmann-La Roche

    Persistent or Recurrent Rare Epithelial Ovarian Tumors

    phase 2 small molecule active

    1 trial

  30. WO46063

    Hoffmann-La Roche

    Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha gene (PIK3CA)-Mutated, hormone receptor-positive (HR-Positive), human epidermal growth factor receptor 2 (HER2)-Negative Locally Advanced or Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  31. WOE-DE-2023-2

    Lacuna Pharma Pty Ltd

    Diabetic sensorimotor polyneuropathy (DSPN)

    phase 2 small molecule active

    1 trial

  32. WSD0922-FU, WSD0922-FU

    Alphapharm Pty Ltd

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  33. WTX-330

    Werewolf Therapeutics

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule active

    2 trials

  34. WVE-006

    Elan Pharma International

    Alpha-1 antitrypsin deficiency (AATD)

    phase 2 small molecule active

    1 trial

  35. Watchful waiting, RO7198457 (autogene cevumeran)

    BioNTech SE

    Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer

    phase 2 small molecule active

    1 trial

  36. WeCareAdvisor

    United Therapeutics Europe Ltd

    Dementia

    phase 2 other completed

    1 trial

  37. Wei Li Bai capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alzheimer Disease

    phase 2 small molecule terminated

    1 trial

  38. Whole cooked beans with rice meals

    United Therapeutics Europe Ltd

    Blood Glucose

    phase 2 other completed

    1 trial

  39. Will receive HH-009 injection 20 mg/kg, Q3W

    Huahui Health

    Advanced or Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  40. Within-Subject test of blinded study medication

    BRIGHT MINDS BIOSCIENCES INC.

    Low Back Pain, Recurrent

    phase 2 small molecule completed

    1 trial

  41. Within-subject test of blinded study medications

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 2 small molecule completed

    1 trial

  42. Workshop

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  43. X-22 Smoking Cessation Product

    Century Therapeutics

    Smoking Cessation

    phase 2 small molecule completed

    1 trial

  44. X-82

    BRIGHT MINDS BIOSCIENCES INC.

    Age-Related Macular Degeneration (AMD)

    phase 2 small molecule terminated

    1 trial

  45. X4P-001

    X4 Pharmaceuticals, Inc

    Clear Cell Renal Cell Carcinoma

    phase 2 small molecule completed

    2 trials

  46. X4P-001

    X4 Pharmaceuticals, Inc

    WHIM Syndrome

    phase 2 small molecule completed

    1 trial

  47. XB2001 or Placebo

    XBiotech Germany GmbH

    Pancreatic Cancer

    phase 2 mab active

    1 trial

  48. XELOX combined with Fruquintinib and Sintilimab

    The First People's Hospital of Lianyungang

    Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.